| Bioactivity | CXCR4 antagonist 10 (compound 21) is a potent antagonist of CXCR4, with the IC50 of 7.8 nM. CXCR4 antagonist 10 plays an important role in cancer research[1]. |
| CAS | 3056005-98-9 |
| Sequence | Ac-Arg-Ala-{Dap}-Arg-{2-Nal}-His-Glu |
| Shortening | Ac-RA-{Dap}-R-{2-Nal}-HE |
| Formula | C44H62N16O10 |
| Molar Mass | 975.06 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Anna Maria Trotta, et al. Comprehensive structural investigation of a potent and selective CXCR4 antagonist via crosslink modification. Eur J Med Chem. 2024 Sep 25:279:116911. |
CXCR4 antagonist 10
CAS: 3056005-98-9 F: C44H62N16O10 W: 975.06
CXCR4 antagonist 10 (compound 21) is a potent antagonist of CXCR4, with the IC50 of 7.8 nM. CXCR4 antagonist 10 plays an
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.